Summary
The effects on intraocular pressure (IOP) and haemodynamics of two β-blockers, arotinolol and timolol, administered topically to the eye, were studied in 6 healthy volunteers in a cross-over trial. 0.5% timolol or 0.5% arotinolol ophthalmic solutions drop was instilled in both eyes of the volunteers at an interval of 48 hours. Timolol lowered IOP by about 31.9% 1 hour after administration and the effect continued until 3 h, whilst arotinolol lowered it significantly 2 h after instillation and the same maximum effect as that of timolol was obtained after 3 h. Arotinolol was detected in blood in all subjects and timolol in blood in one subject, although it was found in all subjects in urine. Both drugs lowered heart rate at rest and attenuated the increase in the double product (products of blood pressure and heart rate) at exercise. The effect of timolol on the double products was larger. Thus, arotinolol and timolol decreased IOP to similar extent, although the maximal effect of arotinolol was delayed. Arotinolol as well as timolol affected haemodynamics through absorption into circulation, but the former had less effect on haemodynamics during exercise.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Affrime MB, Lowenthal DT, Tobert JA, Shirk J, Eidelson RN, Cook T, Onestil G (1980) Dynamics and kinetics of ophthalimic timolol. Clin Pharmacol Ther 27: 471–477
Alvan G, Calissendorff B, Seidman P, Widmark K, Widmark G (1980) Absorption of ocular timolol. Clin Pharmacokinet 5: 95–100
Baldone JA, Hankin JS, Zimmerman TJ (1983) Allergic conjunctivitis associated with timolol therapy in an adult. Ann Ophthalmol 14: 364–365
Bobik A, Jennings GL, Ashely P, Korner PI (1979) Timolol pharmacokinetics and effects on heart rate and blood pressure after acute and chronic administration. Eur J Clin Pharmacol 16: 243–249
Boger WP, Steenert RF, Puliafito CA, Pavan-Langston D (1978) Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Amer J Ophthalmol 86: 8–18
Britman NA (1979) Cardiac effect of topical timolol. N Engl J Med 300: 566
Hara Y, Sato E, Miyagishi A, Aisaka A, Hibino T (1978) Synthesis and β-adrenergic blocking action of a new thiazolythiopropranolomanie derivative. J Pharm Sci 67: 1334–1335
Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H (1979) Pharmacological properties of dl-2-(3′-t-butylamino-2′-hydroxypropylthio)-4-(5′-carbamoyl-2′-thionyl) Thiazole hydrochloride (S-596), a new β-adrenergic blocking agent. Folia Pharmacol Japon 75: 707–720
Heel RC, Brogden RN, Speight TM, Avery GS (1979) Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma. Drugs 17: 38–55
Jones FL, Ekberg NL (1979) Exacerbation of asthma by timolol. N Engl J Med 301: 270
Ohrstrom A, Pandolfi M (1978) Long-term treatment of glaucoma with systemic propranolol. Amer J Ophthalmol 86: 340–344
Pandolfi M, Ohrstrom A (1974) Treatment of ocular hypertension with oral beta-adrenergic agents. Acta Ophthalmol 52: 464–467
Phillips CI, Howitt G, Rowlands DJ (1967) Propranolol as ocular hypotensive agent. Br J Ophthalmol 51: 222–226
Scriabine A (1980) Timolol. In: Scriabine A (ed) Pharmacology in antihypertensive drugs. Raven Press, New York
Sonntag JR, Brindley GO, Shields MB, Arafat NIT, Phelps CD (1979) Timolol and epinephrine; comparison of efficacy and side effects. Arch Ophthalmol 97: 273–277
Tocco DJ, Duncan AEW, deLuna FA, Hucker HB, Gruber VF, Vandenheuvel WJA (1975) Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Dispos 3: 361–370
Zimmerman YJ, Kaufman HE (1977) Timolol: dose response and duration of action. Arch Ophthalmol 95: 605–607
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakashima, M., Uematsu, T., Takiguchi, Y. et al. Effect of ophthalmic administration of S-596 (arotinolol) on intraocular pressure and haemodynamics in healthy volunteers: Comparison with timolol. Eur J Clin Pharmacol 28, 391–395 (1985). https://doi.org/10.1007/BF00544356
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544356